Leading the Research Community

Brian Kennedy, CEO of the Buck Institute, reflects on the Institute's role within the North Bay. “As the Buck Institute’s second CEO, what attracted me to the position was the quality of the work being done here, the quality of the people working here, and the quality of the facilities, all of which can be described as world class."

"The Buck has a leadership role in the region," continues Brian, "and we're proud to be part of a wider community of life science organizations in the North Bay, attracting top talent in fields like research and manufacturing. Given the good that life sciences can offer the world in terms of global impact, and locally in terms of economic impact, we’re pleased to see so many partners from the world of industry and government agencies coming together to make this initiative happen."

"We're part of a community of organizations with similar goals."

Since 1999, the Buck Institute has been at the forefront of research into aging and age-related disease. Collaborations with a variety of universities in the region reflect California’s leadership in the field of aging and stem-cell research, and the opportunities for connectivity that exist between the life sciences in the North Bay and the Bay Area’s leading educational facilities. Brian notes, “At the cutting edge of science, you want to be able to tap into the kind of research that is done both in the commercial field and in the educational sphere. The Bay Area is a great place to build those relationships.”

The Buck is also active in the world of startups, with Brian commenting, “There is so much entrepreneurial activity in the Bay Area, and the life sciences are part of that. Last year we formed a collaboration with Mount Tam Biotechnologies, to license compounds for breakthrough pharmaceutical use. In 2012, we spun off Delos Pharmaceuticals Inc. for pharmaceutical research and development of novel compounds targeting age-related diseases. More recently, we’ve seen LabCures take on some of the challenges involved with funding research. Startups are part of the life sciences ecosystem in the North Bay, and it’s exciting to see them come up with agile solutions to bring things to market. Anyone considering the move to the North Bay should view entrepreneurial presence as a very positive sign. It’s exciting to see them alongside big, established players.”